Peripheral blood mononuclear mobilization with sargramostim (GM-CSF).
Ahmed
T
T
New York Medical College, Valhalla.
Preti
R A
RA
Razis
E
E
Farley
T
T
Lake
D E
DE
Beer
M
M
Cook
P
P
Ciavarella
D
D
D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D018952:Antigens, CD34; D001781:Blood Component Removal; D001943:Breast Neoplasms / Q000628:therapy; D002452:Cell Count; D003114:Colony-Forming Units Assay; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000166:cytology* / Q000187:drug effects* / Q000276:immunology; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage; D014182:Transplantation, Autologous
D015703:Antigens, CD; D018952:Antigens, CD34; D011994:Recombinant Proteins; C081222:sargramostim; D016178:Granulocyte-Macrophage Colony-Stimulating Factor